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SUMMARY
Aims: Regular exercise demonstrated the ability to provide enormous benefits to
many diseases, atherosclerotic-based, degenerative and neoplastic, but also to
grant anti-inflammatory actions, assessed by various authors in different popula-
tions. Despite of these clear benefits, many patients are unable to attain long-term
results through chronic physical activity for different causes. On this basis, the aim
of our study was to assess the metabolic and anti-inflammatory effects of a home-
based programme of fast walking in patients affected by metabolic syndrome
(MS). Materials and methods: We enrolled 176 subjects with MS as stated by
ATP III criteria. Patients were invited to walk for 1 h every day 5 days a week for
24 weeks. The walking velocity was required higher than the one retained ‘com-
fortable’ by the patient, previously assessed in the run-in visit. Monitoring of physi-
cal activity was carried out through an OMRON step counter type Walking Style II.
All the subjects enrolled completed the training period. Results: After the
24 weeks of intervention body mass index changed from 31.59 to 29.23
(p < 0.001); mean waist circumference passed from 105.19 to 100.06 cm
(p < 0.001); mean fasting glucose changed from 119.76 to 114.32 mg/dl
(p < 0.001); for diabetic population (n = 70) mean glicated haemoglobin levels
changed from 7.38% to 6.86% (p < 0.001); total cholesterol levels from 192.15
to 185.78 mg/dl (p < 0.001); HDL cholesterol levels raised from 44.03 to
47.63 mg/dl (p < 0.001); triglycerides levels lowered from 148.29 to 135.20 mg/
dl (p < 0.001); WBC changed from 7361.08 to 7022.56/mm3 (p < 0.001); hs-CRP
from 0.55 to 0.28 mg/dl (p < 0.001); fibrinogen serum levels lowered from
339.68 to 314.86 mg/dl (p < 0.001). Conclusions: A long-term home-based pro-
gramme of aerobic physical activity improves metabolic asset and reduces systemic
inflammation in sedentary people.
What’s known
This topic has been the subject of many studies in
recent years, some of which also conducted using
home monitoring using a pedometer.
The results were not unequivocal as a result of the
heterogeneity of the populations studied, of
different types of exercise proposed, different
intensity and different duration of protocols
What’s new
To our knowledge, no study has evaluated in a
explicit manner the effectiveness of a programme
of home-based exercise as that proposed by us
with the aim to test first the compliance, and
hence the effectiveness towards the biomarkers of
systemic inflammation and of the major
cardiovascular risk factors associated with the
metabolic syndrome.
Introduction
It is well established that regular exercise is a non-
pharmacological therapeutic intervention with an
enormous range of benefits, including reduced mor-
bidity and mortality of atherosclerotic disease (1),
heart failure (2); type 2 diabetes (3), and chronic
obstructive pulmonary disease (4), as well as many
other age-related chronic disorders (5). Among the
different types of exercise, the aerobic training, when
habitually performed, clearly showed to provide sev-
eral favourable metabolic effects against the main
cardiovascular (CV) risk factors (6).
The main well known mechanisms by which phys-
ical training exerts its beneficial efficacy helping to
improve the health status are the favourable effects
on the CV risk factors; the enhancement of muscular
exercise tolerance and improvement of physical fit-
ness; the enhancement of myocardial and peripheral
perfusion; the augmented well-being of the individ-
ual (7). But many other mechanisms responsible for
the protective effects of regular exercise remain to
date unexplained or not completely clear.
Chronic low-grade systemic inflammation, defined
as modest (two to fourfold) elevations in circulating
levels of pro-inflammatory and anti-inflammatory
cytokines, natural occurring cytokine antagonists,
and acute-phase proteins, as well as minor increases
in counts of neutrophils and natural killer cells (8)
seem to be clearly involved in the development and
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progression of atherosclerosis, and may be found
strictly linked to several other chronic pathological
conditions.
Furthermore, chronic subclinical inflammation has
been recently recognized as firmly related to the met-
abolic pathways involved in the insulin resistance, a
key player in the pathogenesis of the metabolic syn-
drome (MS) (9). The finding that increased levels of
C-reactive protein (CRP), the prototypic marker of
inflammation, but also of fibrinogen and leukocyte
count have been associated with the MS and to the
elements of which is compounded (10), confirms the
association between inflammation and MS also when
considered the possible confounding factors.
In this point of view, the promotion of regular
physical activity should be emphasised also to take
advantage of its anti-inflammatory properties (11).
Unfortunately, despite of this great range of bene-
fits, several patients are unable to attend to long-
term physical activity programmes for different rea-
sons: first of all the presence of comorbidities, but
also the lack of facilities, lack of motivation, or per-
ception of too hard training.
Home-based activities seem to be associated with
higher adherence than facility-based activities.
Activities such as walking, jogging, or cycling can
easily be incorporated into routine daily life, whereas
facility-based activities typically require more inten-
tional effort and planning (12), even if the superior-
ity of home-based programmes is clearer in the long
term.
On this basis, we designed a study aimed to test
the hypothesis that a long-term home-based pro-
gramme of physical exercise based on fast
walking might be able to improve the metabolic
asset, the blood pressure levels and the main laborat-
oristic markers of inflammation in sedentary subjects
affected by MS assessed by the ATP III criteria.
Methods
We enrolled 176 subjects (95 men and 81 women,
mean age 59.1  13.6 years) among those who were
referred to the Hospital Units of Medicina Vascolare
and Medicina Interna e Cardioangiologia of the Uni-
versity of Palermo for ambulatory examination in
the period between 01/09/2007 and 31/06/2011. Dur-
ing this period were evaluated approximately 800
possible candidates; 176 patients actually enrolled in
addition to meeting the inclusion criteria of the
study provided significant guarantees of compliance
to the proposed treatment. All subjects were previ-
ously informed about the characteristics of non-
pharmacological intervention that was the object of
study, as well as the duration and methods of imple-
mentation of the clinical, laboratory and instrumen-
tal monitoring. The study design was approved by
the local ethics committee.
Main inclusion criterion was the presence of at
least three findings of MS as stated by ATP III crite-
ria (13).
Exclusion criteria were:
• Age > 80 years
• End-stage renal disease (Stage 5 chronic kidney
disease – GFR <15 ml/min/1.73 m2).
• Every pathologic condition resulting in a limita-
tion of the physical activity of the subject.
• Every CV and/or cerebrovascular event in the last
6 months. The presence of previous CV events (more
than 6 months) did not constitute an exclusion crite-
rion in subjects maintaining their normal physical
and working activities.
• Presence of electrocardiographic evidence of car-
diac arrhythmias, or clinical and/or echocardio-
graphic evidence of cardiac heart failure (EF < 50%)
• In hypertensives, presence of secondary hyperten-
sion.
The initial study procedure included, for all sub-
jects, a comprehensive medical history with complete
physical examination and specific consideration of
CV risk profile, assessment of body mass index
(BMI) calculated as the individual’s body weight
divided by the square of his or her height, waist cir-
cumference and assessment of drug treatment.
At baseline, we evaluated the following blood tests:
total cholesterol, HDL cholesterol, triglyceride, creati-
nine, fibrinogen, haemocromocitometric count, fast-
ing glucose, CRP; furthermore, we performed in all
subjects an ECG and a 24-h ambulatory blood pres-
sure monitoring (ABPM).
The assessment of the level of physical activity was
performed by administration of a specific question-
naire (International Physical Activity Questionnaire).
Only subjects who were being sedentary to the ques-
tionnaire were enrolled.
Cardiovascular risk factors were evaluated on the
basis of the criteria shown below. Hypercholesterola-
emia, hypocholesterolaemia HDL and hypertriglyceri-
daemia were defined as reported in ATP III criteria
(13).
Hypertension was defined as present if subjects
had been previously diagnosed according the World
Health Organization/International Society of Hyper-
tension guidelines and were routinely receiving anti-
hypertensive therapy (14).
Patients were defined as type 2 diabetics if they
had known diabetes treated by diet, oral hypoglycae-
mic drugs or insulin.
Previous cerebrovascular disease (TIA/ischemic
stroke) was assessed by history, specific neurological
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examination performed by specialists, and hospital
or radiological (brain computed tomography or
brain magnetic resonance) records of definite previ-
ous stroke.
The ABPM was performed using a Recorder type
TM – 2430 by A & D Company Limited of Tokyo,
Japan. This device provides an oscillometric record.
Our recorders had previously been validated and rec-
ommended for clinical use (15). The monitoring
equipment was arbitrarily applied at 8.00 A.M. The
cuff was fixed to the non-dominant arm, and three
blood pressure readings were taken concomitantly
with sphygmomanometer measurements to ensure
that the average of the two sets of values did not dif-
fer by > 5 mmHg. The device was set to measure
blood pressure at 15 min intervals during the day (6
a.m. to 10 p.m.) and at 30 min intervals during the
night (10 p.m. to 6 a.m.). During the 24 h of exami-
nation, the patient was informed to hold the arm
immobile at the time of measurements, to keep a
diary of daily activities and to return to the hospital
24 h later. The monitoring was always performed on
a working day and during the normal intake of the
usual anti-hypertensive treatment. The patients had
no access to the ambulatory blood pressure values.
Measurements recorded during the 24 h were
stored on a personal computer and screened as fol-
lows: a 24 h record was rejected for analysis if more
than one third of potential day and night measure-
ments were absent or invalid. The ambulatory BP
values used for statistical analysis are expressed as
24-h average systolic and diastolic pressures, and 24-
h average heart rate.
Patients enrolled initiated a programme of home-
based physical activity centred on fast walking.
Patients were invited to walk for 1 h every day for
5 days a week. The walking velocity was required to be
constant and higher than the one retained ‘comfort-
able’ by the patient, previously assessed in the run-in
visit inviting the patient to walk ‘normally’ in a 10-m
walkway under chronometric control. To every subject
enrolled was asked to register in a diary the daily activ-
ity, indicating the time of start and end of fast walking.
The level of daily physical activity and the adher-
ence to the protocol were assessed through the peri-
odic analysis of data registered by a step counter
provided to every patient. We used an OMRON step
counter type Walking Style II. This device, besides
the function of step counter, also features aerobic
steps. Aerobic steps are counted separately when
walking more than 60 steps per minute and more
than 10 min consecutively. Data about total number
of steps, total number of aerobic steps, total distance
walked, total aerobic distance walked, total energy
expenditure (calories) are stored in the internal
memory of step counter every day for a week maxi-
mum. Every 7 days data should be transferred to PC
and the step counter resetted.
Every week, during the periodic visit because of
data input and storage for the later analysis, was per-
formed a comparison between patient’s diary of
physical activity and speed counter data.
Walking velocity during training period was
obtained analysing the separate aerobic distance cov-
ered recorded by step counter and comparing it with
the time spent walking aerobically as reported in the
patient’s diary. Weekly, during the periodic control
of data, patients enrolled were required to modify
walking velocity and/or walking distance to adhere
the protocol.
In subjects who were taking medication, during the
entire monitoring period was maintained the best pos-
sible therapy. Changes in the drug treatment adminis-
tered were not permitted during the study except for
the requirements related to glycemic control in diabet-
ics to avoid the risk of hypoglycaemia, exacerbated by
the increase in the level of daily physical activity.
The total duration of home-based fast walking
programme was set in 24 weeks.
All the subjects enrolled completed the 24 weeks
of training period.
At the end of the training period were repeated
blood tests, were reassessed anthropometric parame-
ters and was repeated a ABPM.
Statistical analysis
Statistical analysis of quantitative and qualitative
data, included descriptive statistics, was performed
for all the items. Continuous data were expressed as
mean  standard deviation, unless otherwise speci-
fied. The paired samples Student’s t-test procedure
was used to compare the mean differences in contin-
uous anthropometric and laboratoristic variables
before and after the intervention.
Discrete variables were analysed using the v2 and
Fisher’s exact test, as needed.
The McNemar–Bowker analysis was used to test
for symmetry between the dipping and MS pattern
before and after training period. Data were analysed
by the EPI INFO software (version 6.0, CDC, Atlanta,
GA) and the SPSS Software 14.0 version (SPSS, Inc.,
Chicago, IL). All p-values were two-sided and p-val-
ues less than 0.05 were considered to indicate statisti-
cal significance.
Results
Anthropometric, clinical, anamnestic and metabolic
parameters assessed at baseline are reported in
Table 1.
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After the 24 weeks of intervention in the trained
group, BMI changed from 31.59 to 29.23
(p < 0.0001); mean waist circumference passed from
105.19 to 100.06 cm (p < 0.0001); mean fasting glu-
cose changed from 119.76 to 114.32 mg/dl
(p < 0.001); for diabetic population (n = 64) mean
glicated haemoglobin levels changed from 7.38% to
6.86% (p < 0.0001); total cholesterol levels from
192.15 to 185.78 mg/dl (p < 0.001); HDL cholesterol
levels raised significantly from 44.03 to 47.63 mg/dl
(p < 0.0001); triglycerides levels lowered from 148.29
to 135.20 mg/dl (p < 0.0001); white blood count
changed from 7361.08 to 7022.56/mm3 (p < 0.001);
CRP from 0.55 to 0.28 mg/dl (p < 0.001); fibrinogen
serum levels lowered from 339.68 to 314.86 mg/dl.
Evaluation of the data collected through the
pedometer (see Table 2) shows already at 12 weeks
but more at 24 weeks, a significant increase in
physical activity levels of the subjects at home. Mean
total number of steps walked day was reported of
8851  921 at 12 weeks and 9224  771 at 24 weeks.
Mean total number of aerobic steps (evaluated
Table 1 Main anthropometric, clinical and laboratoristic variables on admission and after 24 weeks of home-based
regular exercise in the trained group
Admission After intervention p
Number of patients enrolled 176
M/F (n) 95/81
Age (years) 59.1  7.47
Weight (kg) 86.04  4.73 79.58  3.32 0.0001
BMI 31.59  4.84 29.23  3.79 0.0001
Waist circumference (cm) 105.19  11.78 100.06  9.67 0.0001
Hypertension (n/%) 158 (89.77)
Diabetes (n/%) 64 (36.36)
Glucose blood levels (mg/dl) 119.76  38.38 114.32  28.63 0.0001
HbA1c (diabetics only) (%) 7.38  1.19 6.86  0.67 0.0001
Creatinin (mg/dl) 1.03  0.54
Cr Cl (ml/min) 99.50  40.93
Fibrinogen blood levels (mg/dl) 339.68  63.19 314.86  39.71 0.0001
hs-CRP (mg/dl) 0.55  0.87 0.28  0.27 0.0001
White blood cells (mm³) 7361.08  1659.62 7022.56  1007.86 0.0001
Total Cholesterol blood levels (mg/dl) 192.15  38.61 185.78  37.37 0.001
HDL Cholesterol blood levels (mg/dl) 44.03  10.44 47.63  9.13 0.0001
Triglycerides blood levels (mg/dl) 148.29  57.73 135.2  34.48 0.0001
24-h SBP (mmHg) 133.06  15.23 129.47  11.88 0.0001
24-h DBP (mmHg) 76.62  9.74 74.04  7.83 0.0001
24-h HR (bpm) 71.86  8.99 70.12  7.19 0.0001
Anamnestic cerebrovascular event (n/%) 23 (13.1)
Anamnestic CHD (n/%) 31 (17.6)
Anamnestic PAD (n/%) 10 (5.7)
Liver steatosis (n/%) 122 (69.32)
COPD (n/%) 9 (5.1)
Current smokers (n/%) 32 (18.2)
Statin use (n/%) 62 (35.2)
Data are presented as mean value  SD. BMI, Body Mass Index; Cr Cl, creatinine clearance (calculated through Cockroft and Gault
formule); hs-CRP, high sensitivity C-reactive protein; CHD, coronary heart disease; PAD, peripheral artery disease; SBP, systolic blood
pressure; DBP, diastolic blood pressure; HR, heart rate.
Table 2 Pedometer data in the trained group
12 weeks 24 weeks
Total number of
steps/day
8851  921 9224  771
Total number of
aerobic steps/day
6988  574 7234  610
Total distance
walked (km/day)
6.63  0.69 7.05  0.77
Total aerobic distance
walked (km/day)
5.12  0.44 5.36  0.52
Estimated total energy
expenditure (kcal/day)
425  52 459  68
Data are presented as mean value  SD.
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separately from the pedometer for a walking velocity
higher than 60 steps per minute and more than
10 min consecutively) was 6988  574 at 12 weeks
and 7234  610 at 24 weeks. The mean total distance
covered every day at 12 weeks was of 6.63  0.69 km
of which 5.12  0.44 km aerobic (attributable to fast
walking); at 24 weeks mean total distance covered
every day was of 7.05  0.77 km of which
5.36  0.52 km aerobic. The estimated total energy
expenditure/day because of steps walked was of
425  52 kcal at 12 weeks and 459  68 kcal at the
end of the training period.
Discussion
Over the past decade, until the first description pro-
vided by Ross (16), an impressive amount of evi-
dences has accumulated about the relationship
between systemic inflammation, the atherosclerotic
disease, the CV risk factors, the MS and the endothe-
lial dysfunction (8,9,17).
Although it is yet to be proven whether inflamma-
tion is the cause rather than an effect of the mecha-
nism underlying development of the features of MS
in healthy individuals in these years is strongly
affirming the conviction that a state of subclinical
inflammation represents a pathological background
of several pathologic conditions. It is well established
that inflammatory markers predict the development
of diabetes and glucose disorders (18) and that CRP
appears to be independently associated with incident
isolated systolic hypertension in healthy population
(19). So, relationship between chronic low-grade sys-
temic inflammation, as defined before (8) and the
main findings of MS is very close.
Effectiveness of regular physical exercise against
the main CV risk factors, obtaining a whole anti-ath-
erosclerotic effect, is well established (4,6,7). The
attempt to explain the systemic effects of muscular
contraction lead to the recent evidence that contract-
ing human skeletal muscle releases significant
amounts of cytokines and chemokines, called ‘myo-
kines’ (20). These myokines interact not only with
the immune system, but are supposed also to exert
several metabolic ways, giving a possible explanation
of the metabolic changes following chronic regular
exercise (21). Several of the myokines, released from
the muscle fibres during contraction (Il-6, IL-10, IL-
15, Il-1 receptor antagonis (IL-1ra), soluble TNF-a
receptor (sTNFr), unrelated to muscular damage,
seems to have anti-inflammatory properties (11).
On this basis, several authors tried to demonstrate
that physical exercise has an anti-inflammatory activ-
ity per se, by acting through several mechanisms
involving inhibition of pro-inflammatory, and stimu-
lation of anti-inflammatory pathways. Balducci et al.
(22) recently assessed that physical exercise in type 2
diabetic patients with the MS is associated with a sig-
nificant reduction in hs-CRP and other inflammatory
and insulin resistance biomarkers, independent of
weight loss.
Similar assessments were made in non-diabetic hy-
pertensives and in other populations at high levels of
CV risk by extending the analysis not only to the
main biomarkers of systemic inflammation but also
to pro-inflammatory cytokines such as IL-6, TNF,
IL-1, etc. (23–25). Although the mechanisms by
which the exercise exerts its anti-inflammatory action
are clear only in part, the many existing studies con-
firm for different types of exercise, different intensi-
ties and in different populations the anti-
inflammatory effect in addition to the improvement
of the control of CV risk factors, agreeing that only
programmes for medium-long term are proven to be
effective in achieving these goals.
In this frame, in addition to what is already known
about this topic, our study provides convincing
evidence that a light-to-moderate long-term home-
based programme of aerobic physical activity per-
formed on sedentary adults with MS can help control
the main CV risk factors, providing furthermore a
down-regulation of the systemic inflammation.
Our patients did not reach the threshold of
10,000 steps daily (26), but our aim was to shift the
focus from the number of total steps to the number
of aerobic steps, namely the importance of walking
for a long period of time at a constant speed and
higher than to that considered normal by the
patient.
Our data, although not supported by the assess-
ment of changes in serum levels of inflammatory
cytokines, appear to confirm as evidenced by previ-
ous report (25), demonstrating that a home-based
exercise programme conducted in sedentary subjects
can lead to a significant improvement both of the BP
profile and of the other indices linked to MS, show-
ing also an anti-inflammatory effect as demonstrated
by the reduction in the main indices of systemic
inflammation. But in addition to what was previ-
ously observed, our study provides evidence that
these metabolic improvements added to a reduction
in the main markers of chronic subclinical inflamma-
tion could be obtained without resorting to heavy
programmes, associated with a very low rate of long-
term adherence (12).
In our series, no patients left the study before its
completion. The common experience tells us that
compliance is one of the main problems of physical
activity programmes, and in fact in our study only a
strict preselection has allowed us to achieve a result
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so significant, but this really encouraging result con-
firms that a home-based physical activity programme
centred on fast walking, monitored through the use
of a pedometer, could be well accepted by patients
who are adequately motivated by the doctor. In our
experience, the use of a pedometer may prove to be
an effective tool for promoting healthy lifestyle
changes that include daily physical activity and self-
monitoring of therapeutic goals, as reported else-
where (27). This tool is a possible solution to the
problem of poor compliance (28) shown by many
patients against types of exercise that involve expen-
sive equipment or are not easily accessible.
About the 64 diabetic patients enrolled in our
study, it should be noted that approximately half
were treated with insulin while others taking oral
antidiabetic drugs. In 19 of these (10 treated with
insulin, 9 under oral antidiabetic drugs), it was nec-
essary to reduce the dose of the medication as a
secondary consequence of the reduction in blood
glucose levels under exercise. It should be noted
that also in this subgroup of patients at the end of
the study, there was a statistically significant reduc-
tion in blood glucose and glycosylated haemoglobin
levels, and that this improvement in glycemic con-
trol was achieved despite the reduction in the dos-
age of antidiabetic therapy carried out in some of
them.
In conclusion, a home-based programme of aero-
bic physical activity centred on fast walking moni-
tored through the use of a pedometer provides both
metabolic and anti-inflammatory properties in sed-
entary adults with MS.
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